Immunohematology Metrics

TOP ARTICLES

PAGEVIEWS UNIQUE PAGEVIEWS BOUNCE RATE AVG. TIME SPENT EXIT RATE AVG. GENERATION TIME
Recognizing and resolving ABO discrepancies 98 47 62% 3 98% 3.351s
Separation of multiple antibodies by adsorption with allogeneic red blood cells 110 33 54% 33 79% 3.256s
Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype 109 21 40% 28 57% 2.442s
Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn 47 11 33% 35 27% 3.595s
Thank You 22 9 50% 6 56% 4.701s
The Augustine blood group system, 48 years in the making 18 9 71% 2 78% 3.578s
Autoanti-C in a patient with primary sclerosing cholangitis and autoimmune hemolytic anemia: a rare presentation 30 8 75% 40 63% 2.769s
A field analysis trial comparing the turnaround times of routine and STAT red blood cell immunohematology testing 22 6 50% 8 67% 2.902s
Clinical and laboratory profile of anti-M 15 6 0% 33 17% 3.884s
A detailed flow cytometric method for detection of low-level in vivo red blood  cell–bound IgG, IgA, and IgM 6 6 75% 18 67% 3.922s
The Vel blood group system: a review 19 5 50% 14 80% 2.659s
Hemovigilance and the Notify Library 16 5 0% 13 20% 4.207s
A Caucasian JK*A/JK*B woman with Jk(a+b–) red blood cells, anti-Jkb, and a novel JK*B allele c.1038delG 16 5 100% 2 60% 6.164s
Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab 4 4 75% 0 100% 2.491s
Dithiothreitol treatment of red blood cells 9 4 100% 32 25% 3.722s
ERRATUM 10 4 0% 9 75% 3.548s
How to recognize and resolve reagentdependent reactivity: a review 4 4 0% 12 50% 3.22s
Trends of ABO and Rh phenotypes in transfusion-dependent patients in Pakistan 15 4 50% 4 50% 1.811s
The World Health Organization International Rare Donor Panel 8 2 100% 1 50% 6.591s

PLUMX

METRICS

PLATFORM